Patients with previous exposure to JARDIANCE®

Patients with hypersensitivity to empagliflozin or to any of the excipients

Patients with type 1 diabetes

Patients with history of Diabetic Ketoacidosis (DKA)

Patients with rare hereditary conditions of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption

Patients who are pregnant or are breastfeeding or who plan to become pregnant during the study period

JARDIANCE® Post Marketing Surveillance in Korean Patients With Chronic Kidney Disease (CKD)